S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Stock ideas from the 2024 Microcap Conference
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
MarketBeat Week in Review – 2/19 - 2/23
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Closing prices for crude oil, gold and other commodities
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Stock ideas from the 2024 Microcap Conference
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
MarketBeat Week in Review – 2/19 - 2/23
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Closing prices for crude oil, gold and other commodities
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Stock ideas from the 2024 Microcap Conference
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
MarketBeat Week in Review – 2/19 - 2/23
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Closing prices for crude oil, gold and other commodities
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Stock ideas from the 2024 Microcap Conference
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
MarketBeat Week in Review – 2/19 - 2/23
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Closing prices for crude oil, gold and other commodities
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
NASDAQ:ACHV

Achieve Life Sciences (ACHV) Stock Price, News & Analysis

$3.96
+0.14 (+3.66%)
(As of 02/23/2024 ET)
Today's Range
$3.83
$3.97
50-Day Range
$3.31
$5.14
52-Week Range
$3.03
$10.30
Volume
23,494 shs
Average Volume
36,312 shs
Market Capitalization
$83.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.00

Achieve Life Sciences MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
379.8% Upside
$19.00 Price Target
Short Interest
Bearish
3.17% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.18mentions of Achieve Life Sciences in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.57) to ($1.34) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.49 out of 5 stars

Medical Sector

714th out of 939 stocks

Diagnostic Substances Industry

9th out of 13 stocks

ACHV stock logo

About Achieve Life Sciences Stock (NASDAQ:ACHV)

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

ACHV Stock Price History

ACHV Stock News Headlines

The REAL Reason Americans Keep Falling Behind
In 2023, we saw waves of bank collapses, emergency bailouts, and Treasury bond crashes. Yet big banks are celebrating record earnings in 2024… as more and more ordinary folks struggle to make ends meet every day. The 24-year market veteran who called the Lehman Brothers collapse in 2008 reveals why. 
How to Achieve Work-Life Balance
The REAL Reason Americans Keep Falling Behind
In 2023, we saw waves of bank collapses, emergency bailouts, and Treasury bond crashes. Yet big banks are celebrating record earnings in 2024… as more and more ordinary folks struggle to make ends meet every day. The 24-year market veteran who called the Lehman Brothers collapse in 2008 reveals why. 
ACHV: Not So Fast…
Why Is Achieve Life Sciences (ACHV) Stock Down 44% Today?
Why Is Achieve Life Sciences (ACHV) Stock Down 25% Today?
See More Headlines
Receive ACHV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Achieve Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/16/2023
Today
2/24/2024
Next Earnings (Estimated)
3/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ACHV
CUSIP
68230A10
Employees
20
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$19.00
High Stock Price Target
$20.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+379.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-42,350,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.46 per share

Miscellaneous

Free Float
20,743,000
Market Cap
$83.83 million
Optionable
Optionable
Beta
1.45
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Richard A. B. Stewart (Age 65)
    Executive Chairman
    Comp: $575k
  • Mr. John A. Bencich M.B.A. (Age 47)
    CEO & Director
    Comp: $733.12k
  • Dr. Cindy Jacobs M.D. (Age 66)
    Ph.D., President, Chief Medical Officer & Director
    Comp: $614.25k
  • Mr. Jerry Wan (Age 42)
    Principal Accounting Officer
  • Dr. Anthony Clarke (Age 68)
    Chief Scientific Officer
    Comp: $546k
  • Ms. Jaime Xinos
    Executive Vice President of Commercial














ACHV Stock Analysis - Frequently Asked Questions

Should I buy or sell Achieve Life Sciences stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Achieve Life Sciences in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ACHV shares.
View ACHV analyst ratings
or view top-rated stocks.

What is Achieve Life Sciences' stock price target for 2024?

2 analysts have issued 1-year target prices for Achieve Life Sciences' shares. Their ACHV share price targets range from $18.00 to $20.00. On average, they expect the company's share price to reach $19.00 in the next twelve months. This suggests a possible upside of 379.8% from the stock's current price.
View analysts price targets for ACHV
or view top-rated stocks among Wall Street analysts.

How have ACHV shares performed in 2024?

Achieve Life Sciences' stock was trading at $4.12 on January 1st, 2024. Since then, ACHV shares have decreased by 3.9% and is now trading at $3.96.
View the best growth stocks for 2024 here
.

When is Achieve Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 21st 2024.
View our ACHV earnings forecast
.

How were Achieve Life Sciences' earnings last quarter?

Achieve Life Sciences, Inc. (NASDAQ:ACHV) announced its earnings results on Thursday, March, 16th. The biopharmaceutical company reported ($0.83) earnings per share for the quarter, topping analysts' consensus estimates of ($0.90) by $0.07. During the same period last year, the business posted ($0.76) earnings per share.

When did Achieve Life Sciences' stock split?

Achieve Life Sciences shares reverse split before market open on Friday, July 31st 2020. The 1-20 reverse split was announced on Thursday, July 30th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 30th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Achieve Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Achieve Life Sciences investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Gran Tierra Energy (GTE), Bionano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), KushCo (KSHB) and Pennsylvania Real Estate Investment Trust (PEI).

Who are Achieve Life Sciences' major shareholders?

Achieve Life Sciences' stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (2.86%), Raymond James & Associates (0.73%), Northern Trust Corp (0.48%), Madison Park Capital Advisors LLC (0.05%), Simplex Trading LLC (0.00%) and Citadel Advisors LLC (0.00%).
View institutional ownership trends
.

How do I buy shares of Achieve Life Sciences?

Shares of ACHV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ACHV) was last updated on 2/24/2024 by MarketBeat.com Staff

From Our Partners